Regression in melanoma is significantly associated with a lower regional recurrence rate and better recurrence-free survival.
Subramanian S, Han G, Olson N, Leong SP, Kashani-Sabet M, White RL, Zager JS, Sondak VK, Messina JL, Pockaj B, Kosiorek HE, Vetto J, Fowler G, Schneebaum S, Han D.
Subramanian S, et al. Among authors: han g, han d.
J Surg Oncol. 2022 Feb;125(2):229-238. doi: 10.1002/jso.26678. Epub 2021 Sep 17.
J Surg Oncol. 2022.
PMID: 34535899